SMTL ID : 8hv9.1

Crystal structure of EGFR_TMX in complex with covalently bound fragment 12

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x PE5: 3,6,9,12,15,18,21,24-OCTAOXAHEXACOSAN-1-OL(Non-covalent)

PE5.1: 7 residues within 4Å: Chain A: H.80, N.123, V.126, Q.127, K.130, Q.156, H.157 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.127 Water bridges: A:N.123

1 x N9L: ~{N}-(4-phenylpyridin-2-yl)prop-2-enamide(Covalent)

N9L.2: 10 residues within 4Å: Chain A: L.25, V.33, A.50, C.82, M.97, Q.98, L.99, M.100, L.151, T.161 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:V.33, A:A.50, A:M.97, A:L.151 Hydrogen bonds: A:Q.98, A:M.100, A:T.161

1 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)

DMS.3: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuki, N. et al., A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase. Rsc Med Chem (2023)

Release Date

2023-12-13

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Epidermal growth factor receptor

Related Entries With Identical Sequence